A61K 51/1018
Against material from animals or humans
Official title: {against material from animals or humans}
A61K51/1018 (Against material from animals or humans) appears on 188 US grants and 260 published applications in this corpus.
Search patents in A61K- Granted patents
- 188
- Published applications
- 260
- Assignees
- 145
- Inventors
- 425
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 7 | 0 |
| 1991 | 6 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 5 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 9 | 0 |
| 1998 | 6 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 5 | 3 |
| 2002 | 0 | 3 |
| 2003 | 2 | 8 |
| 2004 | 5 | 10 |
| 2005 | 2 | 5 |
| 2006 | 1 | 5 |
| 2007 | 2 | 7 |
| 2008 | 0 | 6 |
| 2009 | 6 | 11 |
| 2010 | 3 | 11 |
| 2011 | 7 | 17 |
| 2012 | 6 | 11 |
| 2013 | 5 | 11 |
| 2014 | 8 | 16 |
| 2015 | 9 | 15 |
| 2016 | 11 | 16 |
| 2017 | 10 | 17 |
| 2018 | 12 | 15 |
| 2019 | 9 | 12 |
| 2020 | 9 | 10 |
| 2021 | 5 | 13 |
| 2022 | 5 | 8 |
| 2023 | 1 | 6 |
| 2024 | 6 | 7 |
| 2025 | 5 | 9 |
| 2026 | 2 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer21 Jul 2026US 12,685,791 B2Memorial Sloan Kettering Cancer Center
- Calreticulin nanobodies30 Jun 2026US 12,668,622 B2Actinium Pharmaceuticals, Inc.
- CD33 antibodies and methods of using the same to treat cancer14 Oct 2025US 12,441,793 B2Memorial Sloan Kettering Cancer Center
- Compositions and methods for diagnosis of cardiovascular disease14 Oct 2025US 12,441,815 B2The Regents of the University of California
- Therapeutic agents and uses thereof12 Aug 2025US 12,383,637 B2Janssen Biotech, Inc.
- Antibody targeting dll3 and use of antibody8 Oct 2026US 2026/0308240 A1Neukio Biotherapeutics (Shanghai) Co., Ltd.
- Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer1 Oct 2026US 2026/0295100 A1Memorial Sloan Kettering Cancer Center
- Humanised antibodies and uses thereof24 Sep 2026US 2026/0284244 A1Telix Pharmaceuticals (Innovations) Pty Ltd.
- Developing an anti-human cd45 imaging probe for noninvasive detection of human immune cells10 Sep 2026US 2026/0263647 A1Dana-Farber Cancer Institute, Inc.
- Dll3 antigen binding constructs13 Aug 2026US 2026/0234226 A1Imaginab, Inc.
Most cited
By later US patents
- Composition and method for determining the size and location of myocardial infarcts247US 4,036,945 AMassachusetts General Hospital · 1977
- Detection and treatment of infectious and inflammatory lesions159US 4,925,648 AImmunomedics, Inc. · 1990
- Detection and treatment of infections with immunoconjugates155US 5,332,567 AImmunomedics, Inc. · 1994
- Lymphographic and organ imaging method and kit129US 5,101,827 AImmunomedics, Inc. · 1992
- Method for imaging and treating organs and tissues124US 5,697,902 AImmunomedics, Inc. · 1997